Given these heterogeneous results, we conducted the current study to characterize the 90-day risk for hospitalization with pneumonia in a large population of older adults initiated on ACE inhibitors, ARBs, beta blockers (BB) or thiazides in a routine outpatient care setting. The gene discussed is ACE; the disease is pneumonia.